Breast Biopsy is removal of cells or tissues from doubtful areas of breast. These cells or tissues are studied under a microscope to verify the presence of cancer. When a hollow needle is used to remove tissue samples from breast, it is known as core needle biopsy. It is the typical way to rule out or diagnose breast cancer. Core needle biopsy is done for the palpable mass or lump that can be felt, or suspicious area which is seen after mammogram or imaging test. Fine needle biopsy, also known as fine needle aspiration, removes the cells from suspicious lump in breast. The needle used for fine needle biopsy is thinner than the needle used for core needle biopsy. According to the American Cancer Society, 252,710 new cases of invasive breast cancer are projected to be diagnosed in women in the U.S. in 2017. About 63,410 new cases of carcinoma in situ (CIS) are anticipated to be diagnosed (CIS is non-invasive and is the earliest form of breast cancer). About 40,610 women are expected to die from breast cancer.
Different types of biopsies are core needle biopsy, fine needle aspiration biopsy, vacuum-assisted biopsy, image-guided biopsy, incisional biopsy, excisional biopsy, shave biopsy, punch biopsy, endoscopic biopsy, and bone marrow aspiration & biopsy. Two major types of biopsies are needle biopsy and surgical biopsy. Needle biopsy involves usage of a needle to remove tissue sample. Surgical biopsy involves an incision to collect tissue sample. Core needle biopsy is done in imaging centers or hospitals. It is an image guided biopsy procedure. Advantages of core needle biopsy and fine needle biopsy are least chance of bruising or infection. If the lump is confirmed benign, then surgical biopsy is not required. However, there is a chance that the needle may miss the tumor cells, and hence misinterpret it as non-cancerous cell. Fine needle aspiration has false negative rate of 2% to 4%. Hence, fine needle aspiration can be followed by core needle biopsy or surgical biopsy.
Based on utility, the global needle aspiration biopsy market can be categorized into disposable and reusable. In terms of application, the market can be segmented into tumor, inflammation, infection, and others. Based on end-user, the global needle aspiration biopsy market can be classified into diagnostic & imaging centers, hospitals, academics & research centers, and others. Increase in prevalence and incidence of cancer globally and rise in awareness about diseases are the major factors fueling the growth of the global needle aspiration biopsy market. However, technological advancements in imaging such as computed tomography and magnetic resonance imaging are likely to restrain the global needle aspiration biopsy market. Emergence of fluid biopsy can also hamper the growth of the market.
The global needle aspiration biopsy market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is projected to reflect a high CAGR due to significant patient population. Growing awareness among patients as well as health care professionals has led to increase in number of diagnosed cases of cancer in Asia, especially in China and India. North America is projected to dominate the global needle aspiration biopsy market due to factors such as rise in number of reported cancer cases, high per capita health expenditure, and significant investment in R&D for effective treatment alternatives.
Key players in the global needle aspiration biopsy market include Cook Medical, Boston Scientific Corporation, Hologic, Inc., Medax Srl Unipersonale, Cardinal Health, Inc., C. R. Bard, Inc., Becton, Dickinson and Company, Leica Biosystems Nussloch GmbH, Möller Medical GmbH, Hakko Co. Ltd., Argon Medical Devices, Inc., and COMPASS International Innovations, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.